Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 5/20 | 0.78 |
| ▸ | GNB1 | P62873 | 5/20 | 0.78 |
| ▸ | P2RY12 | Q9H244 | 7/20 | 0.73 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.71 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | HPGDS | O60760 | 1/20 | 0.64 |
| ▸ | CHAT | P28329 | 2/20 | 0.62 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.61 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.61 |
| ▸ | ENTPD1 | P49961 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3026737 | 0.99 | GNG2 (0.76) | GNG2GNB1P2RY12P2RY4PHLPP2 | |
| SCHEMBL3026734 | 0.99 | GNG2 (0.76) | GNG2GNB1P2RY12P2RY4PHLPP2 | |
| SCHEMBL13021512 | 0.91 | GNG2 (0.92) | GNG2GNB1P2RY12P2RY4PHLPP2 | |
| SCHEMBL8645343 | 0.91 | GNG2 (0.65) | GNG2GNB1P2RY12P2RY4PHLPP2 | |
| SCHEMBL4650171 | 0.90 | GNG2 (0.78) | GNG2GNB1P2RY12P2RY4PHLPP2 | |
| SCHEMBL11423174 | 0.90 | GNG2 (0.73) | GNG2GNB1P2RY12P2RY4PHLPP2 | |
| SCHEMBL6879091 | 0.89 | GNG2 (0.61) | GNG2GNB1P2RY12P2RY4PHLPP2 | |
| SCHEMBL8642068 | 0.89 | GNG2 (0.61) | GNG2GNB1P2RY12P2RY4PHLPP2 | |
| SCHEMBL17082608 | 0.88 | GNG2 (0.74) | GNG2GNB1P2RY12P2RY4PHLPP2 | |
| SCHEMBL13214010 | 0.88 | GNG2 (0.78) | GNG2GNB1P2RY12P2RY4PHLPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3613486-B1 | METHOD AND INSTALLATION FOR THE PURIFICATION OF EPO AND/OR AN EPO DERIVATIVE | UGA BIOPHARMA GMBH (DE) | 2020-10-07 | — | — | EP | claimed |
| EP-3613486-A1 | METHOD AND INSTALLATION FOR THE PURIFICATION OF EPO AND/OR AN EPO DERIVATIVE | UGA Biopharma GmbH (DE) | 2020-02-26 | — | — | EP | claimed |
| EP-0099859-B1 | PROCESS FOR DYEING DIFFERENTIAL-DYEING FIBRES | CIBA-GEIGY AG (CH) | 1987-04-01 | — | — | EP | claimed |
| EP-3613486-B1 | METHOD AND INSTALLATION FOR THE PURIFICATION OF EPO AND/OR AN EPO DERIVATIVE | UGA BIOPHARMA GMBH (DE) | 2020-10-07 | — | — | EP | disclosed |
| EP-3102637-B1 | METHOD FOR PURIFICATION OF ANTIBODIES, ANTIBODY FRAGMENTS OR ENGINEERED VARIANTS THEREOF USING SPECIFIC ANTHRAQUINONE DYE-LIGAND STRUCTURES | BASF SE (DE) | 2018-04-11 | — | — | EP | disclosed |
| EP-2129653-B1 | NOVEL P2Y12 RECEPTOR ANTAGONISTS | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2017-05-17 | — | — | EP | disclosed |
| US-20160347789-A1 | Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures | BASF SE (DE) | 2016-12-01 | — | — | US | disclosed |
| US-20160347789-A1 | Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures | BASF SE (DE) | 2016-12-01 | — | — | US | disclosed |
| US-8227599-B2 | Adsorbents comprising anthraquinone dye-ligends for the separation of biological materials | BASF SE (DE) | 2012-07-24 | — | — | US | disclosed |
| US-8227599-B2 | Adsorbents comprising anthraquinone dye-ligends for the separation of biological materials | BASF SE (DE) | 2012-07-24 | — | — | US | disclosed |
| EP-1866379-B1 | ADSORBENTS COMPRISING ANTHRAQUINONE DYE-LIGANDS FOR THE SEPARATION OF BIOLOGICAL MATERIALS | BASF SE (DE) | 2011-05-18 | — | — | EP | disclosed |
| EP-0059355-A2 | Use of reactive dyestuffs in dyeing and printing of hydroxylgroups containing fibrous materials | BAYER AG (DE) | 1982-09-08 | — | — | EP | disclosed |
| US-4325869-A | CONTAINING A PYRIMIDINE RING AND ONE OR MORE AZO GROUPS | CIBA-GEIGY CORPORATION (US) | 1982-04-20 | — | — | US | disclosed |
| US-4294580-A | HYDROXYL OR NITROGEN, POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-13 | — | — | US | disclosed |
| US-4255325-A | AZO, ANTHRAQUINONE, FORMAZANE, AND PHTHALOCYANINE DYES; COLOR AND WASHFASTNESS; AMINO HALO TRIAZINE CARBAZIDE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1981-03-10 | — | — | US | disclosed |
| WO-1981000111-A1 | MONO-AZO REACTANTS FOR FIBERS,PRODUCTION PROCESS THEREOF AND UTILIZATION THEREOF | SANDOZ AG (CH) | 1981-01-22 | — | — | WO | disclosed |
| US-4242259-A | TRIAZINE DYES, COTTON | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-30 | — | — | US | disclosed |
| EP-0013765-A1 | Reactive azodyestuffs, their preparation and their use for dyeing materials containing hydroxyl or amide groups | BAYER AG (DE) | 1980-08-06 | — | — | EP | disclosed |
| US-4067864-A | FOR CELLULOSE OR POLYAMIDES | CIBA-GEIGY AG (CH) | 1978-01-10 | — | — | US | disclosed |
| US-3947407-A | ANTHRAQUINONE DYE | CIBA-GEIGY AG (CH) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160347789-A1 | Method for purification of antibodies, antibody fragments or engineered variants thereof using specific anthraquinone dye-ligand structures | ANTXR2, FCGR3B, IGLV6-57 | GNG2 215/4885GNB1 305/4885P2RY12 4455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.